Literature DB >> 6170737

Demyelination in vitro. Absorption studies demonstrate that galactocerebroside is a major target.

C S Raine, A B Johnson, D M Marcus, A Suzuki, M B Bornstein.   

Abstract

Myelinated cultures of mouse spinal cord have been exposed to sera raised in rabbits against whole white matter (anti-WM), myelin basic protein (anti-MBP) and galactocerebroside (anti-GC), the major glycolipid of CNS myelin, to determine which factor in central nervous system (CNS) tissue in vitro is the target of serum demyelinating and myelin swelling antibodies. The sera were tested by radioimmunoassay for activity against MBP and against GC and were also specifically absorbed with MBP, GC and control antigens. Studies were also performed with and without active complement. The findings show that demyelination and myelin swelling in vitro are caused by antibodies against GC and not against MBP. Ultrastructurally, the effects of anti-WM and anti-GC sera with and without complement were indistinguishable. This study demonstrates that GC is a major target in antibody-mediated demyelination.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170737     DOI: 10.1016/0022-510x(81)90140-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

Review 1.  Mechanisms of immune-mediated demyelinating disease of the central nervous system.

Authors:  D Baker; A N Davison
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

2.  Oligodendrocyte-specific autoreactive T cells using an alpha/beta T-cell receptor kill their target without self restriction.

Authors:  V Jewtoukoff; R Lebar; M A Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 3.  Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

Authors:  R W Ledeen; G Chakraborty
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

4.  Intraneural injection of lymphocytes in experimental allergic neuritis.

Authors:  J J Gilbert; T E Feasby; A F Hahn
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

Review 5.  Sphingolipids in multiple sclerosis.

Authors:  Arundhati Jana; Kalipada Pahan
Journal:  Neuromolecular Med       Date:  2010-07-07       Impact factor: 3.843

6.  Demyelinating optic neuropathy with Miller-Fisher syndrome. The case for overlap syndromes with central and peripheral demyelination.

Authors:  P Toshniwal
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

Review 7.  Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands.

Authors:  C A Dyer
Journal:  Mol Neurobiol       Date:  1993       Impact factor: 5.590

8.  In vivo CNS demyelination mediated by anti-galactocerebroside antibody.

Authors:  K Ozawa; T Saida; K Saida; H Nishitani; M Kameyama
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Lipid content of swine influenza and other vaccines.

Authors:  K C Leskawa; E L Hogan; S Dasgupta; J L Chien; R E Erwin; S W Brostoff
Journal:  Lipids       Date:  1986-05       Impact factor: 1.880

10.  The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane.

Authors:  R Lebar; C Lubetzki; C Vincent; P Lombrail; J M Boutry
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.